CoChat

Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures

Open access
Singhi, Aatur D, Nikiforova, Marina N, Chennat, Jennifer, Papachristou, Georgios I, Khalid, Asif, Rabinovitz, Mordechai, Das, Rohit, Sarkaria, Savreet, Ayasso, M Samir, Wald, Abigail I, Monaco, Sara E, Nalesnik, Michael, Ohori, N Paul, Geller, David, Tsung, Allan, Zureikat, Amer H, Zeh, Herbert, Marsh, J Wallis, Hogg, Melissa, Lee, Kenneth, Bartlett, David L, Pingpank, James F, Humar, Abhinav, Bahary, Nathan, Dasyam, Anil K, Brand, Randall, Fasanella, Kenneth E, McGrath, Kevin, Slivka, Adam · 2020 · Gut
Cited by 176

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Objective: Despite improvements in imaging, serum CA19-9 and pathological evaluation, differentiating between benign and malignant bile duct strictures remains a diagnostic conundrum. Recent developments in next-generation sequencing (NGS) have opened new opportunities for early detection and management of cancers but, to date, have not been rigorously applied to biliary specimens. Design: We prospectively evaluated a 28-gene NGS panel (BiliSeq) using endoscopic retrograde cholangiopancreatography-obtained biliary specimens from patients with bile duct strictures. The diagnostic performance of serum CA19-9, pathological evaluation and BiliSeq was assessed on 252 patients (57 trainings and 195 validations) with 346 biliary specimens. Results: The sensitivity and specificity of BiliSeq for malignant strictures was 73% and 100%, respectively. In comparison, an elevated serum CA19-9 and pathological evaluation had sensitivities of 76% and 48%, and specificities of 69% and 99%, respectively. The combination of BiliSeq and pathological evaluation increased the sensitivity to 83% and maintained a specificity of 99%. BiliSeq improved the sensitivity of pathological evaluation for malignancy from 35% to 77% for biliary brushings and from 52% to 83% for biliary biopsies. Among patients with primary sclerosing cholangitis (PSC), BiliSeq had an 83% sensitivity as compared with pathological evaluation with an 8% sensitivity. Therapeutically relevant genomic alterations were identified in 20 (8%) patients. Two patients with ERBB2-amplified cholangiocarcinoma received a trastuzumab-based regimen and had measurable clinicoradiographic response. Conclusions: The combination of BiliSeq and pathological evaluation of biliary specimens increased the detection of malignant strictures, particularly in patients with PSC. Additionally, BiliSeq identified alterations that may stratify patients for specific anticancer therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2018-317817

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 176

Metadata

Authors
Singhi, A. D., Nikiforova, M. N., Chennat, J., Papachristou, G. I., Khalid, A., Rabinovitz, M., Das, R., Sarkaria, S., Ayasso, M. S., Wald, A. I., Monaco, S. E., Nalesnik, M., Ohori, N. P., Geller, D., Tsung, A., Zureikat, A. H., Zeh, H., Marsh, J. W., Hogg, M., Lee, K., Bartlett, D. L., Pingpank, J. F., Humar, A., Bahary, N., Dasyam, A. K., Brand, R., Fasanella, K. E., McGrath, K., & Slivka, A.
Venue
Gut
Publisher
BMJ
Published
2019-04-10
Volume
69
Issue
1
Pages
52-61
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2938824412
Cited by
176
References
6
FWCI
13.67
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures. https://app.cochat.ai/papers/10.1136/gutjnl-2018-317817
The paper
Singhi, A. D., Nikiforova, M. N., Chennat, J., Papachristou, G. I., Khalid, A., Rabinovitz, M., Das, R., Sarkaria, S., Ayasso, M. S., Wald, A. I., Monaco, S. E., Nalesnik, M., Ohori, N. P., Geller, D., Tsung, A., Zureikat, A. H., Zeh, H., Marsh, J. W., Hogg, M., . . . Slivka, A. (2020). Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures. Gut. https://doi.org/10.1136/gutjnl-2018-317817

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.